BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ · Healthcare
BridgeBio Oncology Therapeutics, Inc. Price to Book Ratio 2025–2026
Price to book (P/B) ratio for BridgeBio Oncology Therapeutics, Inc. (BBOT): market cap divided by shareholder equity. As of March 31, 2026 it is 1.74.
From: 09/30/2025To: 03/31/2026
Stock Price
Book Value
Price to Book
BridgeBio Oncology Therapeutics, Inc. Price to Book Ratio — FAQ
BridgeBio Oncology Therapeutics, Inc. (BBOT) price to book ratio over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBOT's price to book ratio history?
The chart and table above show BridgeBio Oncology Therapeutics, Inc.'s price to book ratio by year and by quarter, including the growth rate.